Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals develops medicines for rare diseases that affect the liver and brain. The company sells LIVMARLI, a pill that reduces itching in patients with Alagille syndrome, a rare inherited liver condition. It also markets Cholbam and Chenodal, older medicines for rare bile acid and gallstone disorders. Mirum is testing several experimental drugs for other rare diseases, including chronic liver disease and a genetic disorder called fragile X syndrome.